Dolutegravir-based first-line antiretroviral therapy prescription
preferred first-line regimen
tests per year, worldwide (WHO public health guidance), from ART start, continuous
“DTG in combination with an NRTI backbone is recommended as the preferred first-line regimen for people living with HIV initiating ART.”
- Kind of source
- Clinical guideline
- Read on
- 2026-11-06
- Daily check
- Quote found at the source on 2026-11-06
- What to know
- Strong recommendation for adults and adolescents. Treatment is lifelong, so the prescription history is continuous.
Used in
Kept as evidence; no figure on the platform is computed from it yet.